Michele Merli

4.6k total citations
64 papers, 1.1k citations indexed

About

Michele Merli is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Michele Merli has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pathology and Forensic Medicine, 38 papers in Genetics and 27 papers in Oncology. Recurrent topics in Michele Merli's work include Lymphoma Diagnosis and Treatment (47 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Viral-associated cancers and disorders (21 papers). Michele Merli is often cited by papers focused on Lymphoma Diagnosis and Treatment (47 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Viral-associated cancers and disorders (21 papers). Michele Merli collaborates with scholars based in Italy, United States and France. Michele Merli's co-authors include Luca Arcaini, Francesco Passamonti, Mario Lazzarino, Emanuela Boveri, Cristiana Pascutto, Sara Rattotti, Elisa Rumi, Chiara Elena, Marco Paulli and Daniela Pietra and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michele Merli

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Merli Italy 17 705 474 329 303 286 64 1.1k
Ferdinando Frigeri Italy 19 483 0.7× 437 0.9× 339 1.0× 211 0.7× 422 1.5× 60 1.2k
Francesc Cobo Spain 18 650 0.9× 573 1.2× 367 1.1× 266 0.9× 352 1.2× 38 1.2k
Katayoun Jondeau France 8 339 0.5× 305 0.6× 245 0.7× 121 0.4× 253 0.9× 18 885
Masahiro Yokoyama Japan 15 325 0.5× 575 1.2× 461 1.4× 116 0.4× 79 0.3× 61 1.0k
Sara Rattotti Italy 16 595 0.8× 655 1.4× 278 0.8× 148 0.5× 121 0.4× 44 963
Jamile M. Shammo United States 17 587 0.8× 227 0.5× 305 0.9× 429 1.4× 874 3.1× 79 1.5k
Karin Fahl Wader Norway 12 169 0.2× 241 0.5× 263 0.8× 213 0.7× 122 0.4× 20 603
Louis Terriou France 20 567 0.8× 242 0.5× 177 0.5× 138 0.5× 807 2.8× 112 1.8k
T. Economopoulos Greece 18 446 0.6× 318 0.7× 359 1.1× 178 0.6× 382 1.3× 45 1.1k
Pascal Godmer France 13 113 0.2× 136 0.3× 128 0.4× 189 0.6× 157 0.5× 31 802

Countries citing papers authored by Michele Merli

Since Specialization
Citations

This map shows the geographic impact of Michele Merli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Merli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Merli more than expected).

Fields of papers citing papers by Michele Merli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Merli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Merli. The network helps show where Michele Merli may publish in the future.

Co-authorship network of co-authors of Michele Merli

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Merli. A scholar is included among the top collaborators of Michele Merli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Merli. Michele Merli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitolo, Umberto, Michele Merli, Lalita Norasetthada, et al.. (2024). Phase 3 trial of odronextamab plus lenalidomide versus rituximab plus lenalidomide in relapsed/refractory (R/R) follicular lymphoma (FL) and marginal zone lymphoma (MZL; OLYMPIA-5).. Journal of Clinical Oncology. 42(16_suppl). TPS7094–TPS7094. 2 indexed citations
2.
Merli, Michele, Andrea Costantini, Silvio Tafuri, et al.. (2024). Management of vaccinations in patients with non‐Hodgkin lymphoma. British Journal of Haematology. 204(5). 1617–1634. 1 indexed citations
3.
Salvini, Marco, et al.. (2024). Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer. JAMA Oncology. 10(3). 405–405. 1 indexed citations
4.
Annibali, Ombretta, Michele Merli, Carla Minoia, et al.. (2024). Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centers. Leukemia & lymphoma. 66(1). 109–114.
5.
Zilioli, Vittorio Ruggero, Emanuele Cencini, Sonya De Lorenzo, et al.. (2024). Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience. Hematological Oncology. 42(3). e3273–e3273.
6.
7.
Ladetto, Marco, Matthew Ku, Luca Arcaini, et al.. (2024). Mosunetuzumab and Zanubrutinib in Relapsed/Refractory Follicular Lymphoma Patients (MOZART): A Phase II, Chemo-Free Trial from Fondazione Italiana Linfomi (FIL). Blood. 144(Supplement 1). 3042.1–3042.1. 1 indexed citations
8.
Martin, Vittoria, Leonardo Campiotti, Michele Merli, et al.. (2023). High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy. Cancer Genetics. 274-275. 1–9. 2 indexed citations
9.
Lucioni, Marco, Giuseppe Neri, Michele Merli, et al.. (2023). T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms. International Journal of Molecular Sciences. 24(9). 7813–7813. 6 indexed citations
10.
Merli, Michele & Luca Arcaini. (2022). Management of marginal zone lymphomas. Hematology. 2022(1). 676–687. 4 indexed citations
11.
Merli, Michele, Irene Defrancesco, Carlo Visco, et al.. (2020). Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & lymphoma. 61(9). 2122–2128. 13 indexed citations
12.
Defrancesco, Irene, Sara Rattotti, Michele Merli, et al.. (2020). HCV infection and non-Hodgkin lymphomas: an evolving story. Clinical and Experimental Medicine. 20(3). 321–328. 11 indexed citations
13.
Merli, Michele, Giuseppe Carli, Luca Arcaini, & Carlo Visco. (2016). Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. World Journal of Gastroenterology. 22(38). 8447–8447. 19 indexed citations
14.
Passamonti, Francesco, Margherita Maffioli, Michele Merli, Andrea Ferrario, & Domenica Caramazza. (2012). Clinical Predictors of Outcome in MPN. Hematology/Oncology Clinics of North America. 26(5). 1101–1116. 5 indexed citations
15.
Arcaini, Luca, Silvia Zibellini, Francesco Passamonti, et al.. (2009). Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires. Blood Cells Molecules and Diseases. 42(3). 286–291. 23 indexed citations
16.
Paulli, Marco, Luca Arcaini, Marco Lucioni, et al.. (2009). Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Annals of Oncology. 21(6). 1189–1195. 40 indexed citations
17.
Arcaini, Luca, Francesca Montanari, Emilio Paolo Alessandrino, et al.. (2008). Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals of Oncology. 19(7). 1331–1335. 25 indexed citations
18.
Castagnola, Carlo, Chiara Elena, & Michele Merli. (2008). Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia. Haematologica. 93(2). e28–e28. 2 indexed citations
19.
Visco, Carlo, Luca Arcaini, Ercole Brusamolino, et al.. (2006). Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Annals of Oncology. 17(9). 1434–1440. 68 indexed citations
20.
Corvaja, N., et al.. (1977). Slow rate transport of horseradish peroxidase in toads. Brain Research. 128(3). 537–541. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdinando Frigeri Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Katayoun Jondeau Breakdown of academic impact, for papers by Masahiro Yokoyama Breakdown of academic impact, for papers by Sara Rattotti Breakdown of academic impact, for papers by Jamile M. Shammo Breakdown of academic impact, for papers by Karin Fahl Wader Breakdown of academic impact, for papers by Louis Terriou Breakdown of academic impact, for papers by T. Economopoulos Breakdown of academic impact, for papers by Pascal Godmer
Rankless by CCL
2026